New compound discovered in fight against inflammatory disease

September 22, 2017, University of Manchester

A 10-year study by University of Manchester scientists for a new chemical compound that is able to block a key component in inflammatory illness has ended in success.

The news follows last year's discovery by Dr David Brough and his team that the drug mefenamic acid reversed memory loss and in a model of Alzheimer's .

But in the new study Dr Brough and colleague Dr Sally Freeman have developed new and more potent inhibitors of inflammation.

The new inhibit a specific part of an inflammatory response called the 'inflammasome' which is implicated in Alzheimer's disease, cardiovascular disease, cancer and many others.

The findings are published today in the journal Cell Chemical Biology with contributions from PhD students Alex Baldwin and Mike Daniels, and postdoctoral researcher Dr Jack Rivers-Auty, amongst a network of other collaborators.

The research is timely, following the recently published CANTOS clinical trial results by US researchers, which found that reducing inflammation with a drug in people who have had a heart attack reduces the risk of further heart attacks and cancer.

The new molecules discovered by Drs Brough and Freeman published today target the same pathway.

Credit: University of Manchester

The Manchester team used powerful biological and chemical methods to generate new and effective molecules which can now be further developed and tested.

Dr Brough said: "The discovery of these new compounds is really exciting and will allow us to further understand inflammation and disease."

"Our new molecules specifically hit an important inflammatory mechanism that occurs in disease."

Dr Sally Freeman said: "It's a tremendous starting point for a new generation of molecules which can be developed to target inflammatory disease."

Dr Jack Rivers-Auty said: "It is becoming clear that inflammation is directly involved in many diseases and this is an exciting step towards specifically targeting harmful ."

Explore further: Treatment option for Alzheimer's disease possible

More information: Alex G. Baldwin et al. Boron-Based Inhibitors of the NLRP3 Inflammasome, Cell Chemical Biology (2017). DOI: 10.1016/j.chembiol.2017.08.011

Related Stories

Treatment option for Alzheimer's disease possible

August 11, 2016
A research project has shown that an experimental model of Alzheimer's disease can be successfully treated with a commonly used anti-inflammatory drug.

Scientists make surprising finding in stroke research

March 16, 2015
Scientists at The University of Manchester have made an important new discovery about the brain's immune system that could lead to potential new treatments for stroke and other related conditions.

High-fat diet leads to same intestinal inflammation as a virus

June 22, 2017
A new study by scientists at UCLA found that when mice eat a high-fat diet, the cells in their small intestines respond the same way they do to a viral infection, turning up production of certain immune molecules and causing ...

Researchers find molecular trigger for brain inflammation

April 27, 2017
Brain inflammation is a key component of multiple sclerosis, Alzheimer's, Parkinson's, ALS, and most other major neurodegenerative diseases. How inflammation starts, how it's sustained, and how it contributes to these diseases ...

Inflammatory disease trigger revealed

February 22, 2017
Institute scientists have revealed a potent inflammatory molecule released by dying cells triggers inflammation during necroptosis, a recently described form of cell death linked to inflammatory disease.

Recommended for you

Sugar, a 'sweet' tool to understand brain injuries

October 15, 2018
Australian researchers have developed ground-breaking new technology which could prove crucial in treating brain injuries and have multiple other applications, including testing the success of cancer therapies.

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

Microbiome profiling reveals associations with ulcerative colitis severity, treatment

October 11, 2018
A study of gut microbes from more than 400 children points to how the microbiome behaves in this inflammatory bowel disease.

Genomic study finds a new role for microRNAs as predictors of Crohn's disease progression

October 4, 2018
Crohn's disease is a lifelong condition characterized by a fluctuating course of gastro-intestinal inflammation with repeated flares and remissions. Any part of the alimentary tract from the mouth to the anus can be affected ...

Immune system's balancing act keeps bowel disease in check

October 2, 2018
Australian researchers have uncovered clues in the immune system that reveal how the balance of 'good' gut bacteria is maintained. The information could help in the prevention and treatment of inflammatory bowel disease (IBD).

Single cell analysis paves the way for better treatments for IBD

October 2, 2018
Researchers at MRC HIU examined the large intestine using sophisticated single cell technology, in work that paves the way for better treatments for IBD.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.